Session 2 : Translational Science

Translational Science by Rejiv Rajendranath

Chairpersons :

Ramesh Nimmagadda, R K Deshpande

Speaker :

Rejiv Rajendranath

PAM50 intrinsic subtype as a predictor of pathological complete response following neoadjuvant dual HER2 blockade without chemotherapy in HER2-positive breast cancer: First results of the PAMELA clinical trial

Author: Prat Aparicio A

Conference: 2016 SABCS S3-03

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

Author: Fatima Cardoso

Conference: AACR Abstract CT039 & N Engl J Med2016; 375:717729

Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy

Author: Richard Buus

Reference: JNCI J Natl Cancer Inst (2016) 108(11):djw149